CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisEileen O’Meara, Bruce Sussex, Michael Chan et al.|Canadian Journal of Cardiology|2020Cited by 121